Abstract on STA363's clinical effect on disc volume has been accepted for presentation at an important congress
Stayble Therapeutics AB ("Stayble" or the "Company") announces that the Company's scientific abstract regarding the treatment concept for herniated discs has been accepted for a poster presentation at the International Society for the Study of the Lumbar Spine (ISSLS) annual meeting in Milan, Italy, on 27-31 May 2024.The poster presents the STA363 results on lumbar discs from the phase 2b study in degenerative disc disease (DDD) and explains why STA363 can have a treatment effect in patients with herniated discs. The result demonstrates a statistically significant reduction in both disc